4DPharma PLC   Report issue

For profit Phase 1 Phase 2
Founded: Aberdeen United Kingdom (2014)
Status: No NME R&D (2014)

Organization Overview

First Clinical Trial
2018
NCT03637803
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

4D pharma plc | 4DPharma PLC

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Asthma (Phase 2)

Carcinoma, Renal Cell (Phase 1)

Irritable Bowel Syndrome (Phase 2)

Kidney Neoplasms (Phase 1)

Neoplasms (Phase 1)

Pancreatic Neoplasms (Phase 1)

Syndrome (Phase 2)

Urethral Neoplasms (Phase 1)

Uterine Neoplasms (Phase 1)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 8
  • # of Trial APIs: 7